These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24386508)

  • 1. Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss.
    Robinson GL; Robinson JP; Lastwika KJ; Holmen SL; Vanbrocklin MW
    Genes Cancer; 2013 Nov; 4(11-12):476-85. PubMed ID: 24386508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ink4a/Arf loss promotes tumor recurrence following Ras inhibition.
    Vanbrocklin MW; Robinson JP; Lastwika KJ; McKinney AJ; Gach HM; Holmen SL
    Neuro Oncol; 2012 Jan; 14(1):34-42. PubMed ID: 22015595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.
    Robinson JP; VanBrocklin MW; Guilbeault AR; Signorelli DL; Brandner S; Holmen SL
    Oncogene; 2010 Jan; 29(3):335-44. PubMed ID: 19855433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive Ras signaling and
    Sewastianik T; Jiang M; Sukhdeo K; Patel SS; Roberts K; Kang Y; Alduaij A; Dennis PS; Lawney B; Liu R; Song Z; Xiong J; Zhang Y; Lemieux ME; Pinkus GS; Rich JN; Weinstock DM; Mullighan CG; Sharpless NE; Carrasco RD
    Blood Adv; 2017 Nov; 1(25):2361-2374. PubMed ID: 29296886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.
    VanBrocklin MW; Robinson JP; Lastwika KJ; Khoury JD; Holmen SL
    Pigment Cell Melanoma Res; 2010 Aug; 23(4):531-41. PubMed ID: 20444198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.
    Moore LM; Holmes KM; Smith SM; Wu Y; Tchougounova E; Uhrbom L; Sawaya R; Bruner JM; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16675-9. PubMed ID: 19805356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.
    Yang G; Curley D; Bosenberg MW; Tsao H
    Cancer Res; 2007 Jun; 67(12):5649-57. PubMed ID: 17575131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
    Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
    Debies MT; Gestl SA; Mathers JL; Mikse OR; Leonard TL; Moody SE; Chodosh LA; Cardiff RD; Gunther EJ
    J Clin Invest; 2008 Jan; 118(1):51-63. PubMed ID: 18060046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.
    Aguirre AJ; Bardeesy N; Sinha M; Lopez L; Tuveson DA; Horner J; Redston MS; DePinho RA
    Genes Dev; 2003 Dec; 17(24):3112-26. PubMed ID: 14681207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of Raf-1 induces glioma formation in mice.
    Lyustikman Y; Momota H; Pao W; Holland EC
    Neoplasia; 2008 May; 10(5):501-10. PubMed ID: 18472967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.
    Wang Z; Banerjee S; Ahmad A; Li Y; Azmi AS; Gunn JR; Kong D; Bao B; Ali S; Gao J; Mohammad RM; Miele L; Korc M; Sarkar FH
    PLoS One; 2011; 6(6):e20537. PubMed ID: 21673986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRAF kinase domain promotes the development of gliomas in vivo.
    Shin CH; Grossmann AH; Holmen SL; Robinson JP
    Genes Cancer; 2015 Jan; 6(1-2):9-18. PubMed ID: 25821557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
    Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
    Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans.
    Liu KW; Feng H; Bachoo R; Kazlauskas A; Smith EM; Symes K; Hamilton RL; Nagane M; Nishikawa R; Hu B; Cheng SY
    J Clin Invest; 2011 Mar; 121(3):905-17. PubMed ID: 21393858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.